The Risk of Arterial Thrombosis in Patients With Chronic Myeloid Leukemia Treated With Second and Third Generation BCR-ABL Tyrosine Kinase Inhibitors May Be Explained by Their Impact on Endothelial Cells: An In-Vitro Study

接受第二代和第三代 BCR-ABL 酪氨酸激酶抑制剂治疗的慢性粒细胞白血病患者发生动脉血栓形成的风险可能通过其对内皮细胞的影响来解释：一项体外研究